<DOC>
	<DOCNO>NCT00975949</DOCNO>
	<brief_summary>The purpose study compare neurodevelopmental outcome quality life fluconazole-treated placebo-treated patient enrol fluconazole prophylaxis study occur investigator ' neonatal intensive care unit ( NICU ) 1998-2000 .</brief_summary>
	<brief_title>Neurodevelopmental Outcomes Fluconazole Prophylaxis</brief_title>
	<detailed_description>Invasive fungal infection preterm infant associate significant morbidity mortality . Mortality infect infant &lt; 1000 grams 26-66 % neurodevelopmental impairment occur 57 % .1-13 Between 1998-2000 conduct randomize placebo control trial fluconazole prophylaxis 100 infant &lt; 1000 gram birth ( IRB-HSR # 9389 ) . Invasive fungal infection occur none fluconazole-treated patient compare 20 % placebo group . Following study efficacy confirm multicenter randomize control trial 7 retrospective study . One major issue remain whether fluconazole-treated infant well neurodevelopmental outcomes well safe without increase neurodevelopmental impairment . Neurodevelopmental outcome assess test examination parental child questionnaire . In addition , quality life important context outcome . Recent conceptualization quality life recognize multidimensional nature quality life , include psychological social functioning , consistent World Health Organization 's definition health `` absence disease infirmity , presence physical , mental , social well-being . '' The World Health Organization subsequently emphasize grow consensus quality life subjective experience , define `` individual ' perception position life context culture value system live , relation goal , expectation , standard , concern . '' To address issue , aim study compare neurodevelopmental outcome quality life fluconazole-treated placebo-treated patient initial study</detailed_description>
	<mesh_term>Fluconazole</mesh_term>
	<criteria>Parents guardians infant survive enrolled initial study fluconazole prophylaxis prevention fungal colonization infection preterm infant &lt; 1000 grams Persons meeting inclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>7 Years</minimum_age>
	<maximum_age>10 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>fluconazole prophylaxis</keyword>
	<keyword>fungal colonization</keyword>
	<keyword>fungal infection</keyword>
	<keyword>preterm infant</keyword>
	<keyword>long term outcome</keyword>
	<keyword>quality life</keyword>
</DOC>